| scholarly article | Q13442814 |
| P2093 | author name string | Guillaume Bollée | |
| Michel Daudon | |||
| Pierre Cochat | |||
| P2860 | cites work | Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis | Q24337342 |
| Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient | Q28242738 | ||
| Adenine phosphoribosyltransferase deficiency | Q28268826 | ||
| Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency | Q28273050 | ||
| Adenine phosphoribosyltransferase: a simple spectrophotometric assay and the incidence of mutation in the normal population | Q28284029 | ||
| Shedding light on the chemical diversity of ectopic calcifications in kidney tissues: diagnostic and research aspects | Q28478092 | ||
| Kidney transplantation in primary oxalosis: data from the EDTA Registry | Q33771313 | ||
| Hereditary causes of kidney stones and chronic kidney disease | Q34066169 | ||
| A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria | Q34222976 | ||
| Transplantation Outcomes in Primary Hyperoxaluria | Q34247162 | ||
| Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2. | Q34278719 | ||
| Urinary oxalate and glycolate excretion and plasma oxalate concentration | Q35626555 | ||
| Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy | Q35827275 | ||
| Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant | Q35977167 | ||
| Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure | Q36030204 | ||
| Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele | Q36102388 | ||
| International registry for primary hyperoxaluria | Q36165824 | ||
| Stone analysis | Q36396134 | ||
| Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice | Q37621553 | ||
| An update on primary hyperoxaluria | Q38017938 | ||
| Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions | Q38061207 | ||
| Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria | Q38119723 | ||
| 2,8-Dihydroxyadenine urolithiasis: a not so rare inborn error of purine metabolism | Q38221151 | ||
| Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction. | Q38545091 | ||
| 2,8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant | Q39582515 | ||
| Management of primary hyperoxaluria: efficacy of oral citrate administration | Q40898355 | ||
| Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies | Q41480321 | ||
| Decreased kidney function and crystal deposition in the tubules after kidney transplant | Q43123317 | ||
| Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure | Q43197398 | ||
| Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome | Q43218013 | ||
| Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction | Q43590482 | ||
| The oesophagus and chest pain | Q43719944 | ||
| Clinical features and genotype of adenine phosphoribosyltransferase deficiency in iceland. | Q43726175 | ||
| Adenine phosphoribosyltransferase deficiency with renal deposition of 2,8-dihydroxyadenine leading to nephrolithiasis and chronic renal failure | Q43785934 | ||
| Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort | Q43990085 | ||
| Adenine phosphoribosyltransferase deficiency in children | Q44394127 | ||
| One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience | Q44681423 | ||
| Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease | Q44855203 | ||
| Clinical implications of mutation analysis in primary hyperoxaluria type 1. | Q44978371 | ||
| Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. | Q45028890 | ||
| Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation. | Q46229637 | ||
| Peculiar morphology of stones in primary hyperoxaluria | Q46506012 | ||
| Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure | Q46835914 | ||
| Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. | Q53962920 | ||
| Common characteristics of mutant adenine phosphoribosyltransferases from four separate Japanese families with 2,8-dihydroxyadenine urolithiasis associated with partial enzyme deficiencies. | Q54459492 | ||
| Crystalluria: A clinically useful investigation in children with primary hyperoxaluria post-transplantation: Technical Note | Q58424374 | ||
| Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment | Q63441478 | ||
| Complete deficiency of adenine phosphoribosyltransferase. Report of a family | Q67578835 | ||
| Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria | Q68139410 | ||
| Correlation between adenylate metabolizing enzymes and adenine nucleotide levels of erythrocytes during blood storage in various media | Q70373577 | ||
| Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure | Q71671263 | ||
| Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant | Q72042739 | ||
| Acute renal failure in a middle-aged woman with 2,8-dihydroxyadeninuria | Q73718956 | ||
| Recurrence of 2,8-dihydroxyadenine tubulointerstitial lesions in a kidney transplant recipient with a primary presentation of chronic renal failure | Q74502482 | ||
| Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure | Q78016647 | ||
| Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1 | Q80217888 | ||
| Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis | Q80219149 | ||
| Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1 | Q80313618 | ||
| Immediate postoperative intensive care treatment of pediatric combined liver-kidney transplantation: outcome and prognostic factors | Q84039103 | ||
| Sequential liver and kidney transplantation from a single living donor in two young adults with primary hyperoxaluria type 1 | Q86485408 | ||
| Primary hyperoxaluria | Q87252608 | ||
| Failure of isolated kidney transplantation in a pediatric patient with primary hyperoxaluria type 2 | Q87404908 | ||
| Febuxostat in adenosine phosphoribosyltransferase deficiency | Q88087106 | ||
| 2,8-Dihydroxyadenine urolithiasis, an underdiagnosed disease | Q95792891 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney transplantation | Q740909 |
| primary hyperoxaluria | Q7243137 | ||
| P304 | page(s) | 31 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Canadian journal of kidney health and disease | Q27726098 |
| P1476 | title | Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria | |
| P478 | volume | 2 |
| Q94673556 | 1-Methyluric Acid Nephropathy |
| Q57796030 | APRT deficiency: the need for early diagnosis |
| Q89837566 | Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy |
| Q98158881 | Combined liver-kidney transplant in a 21-month-old child with type 1 primary hyperoxaluria-The perioperative challenges |
| Q40958913 | Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation |
| Q97066891 | Outcomes of liver-kidney transplantation in patients with primary hyperoxaluria: an analysis of the scientific registry of transplant recipients database |
| Q93259088 | Precision medicine in renal stone-formers |
| Q92870946 | Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review |
| Q47106753 | Safety of potassium-bearing citrate in patients with renal transplantation: A case report |
Search more.